ArticleToxics2026
Nitrogen and Boron Co-Doped Biochar-Activated Peroxymonosulfate for Degradation of Tetracycline: Performance and Mechanisms.
Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bacteria-nanoplastic interactions: mechanisms, ecological consequences, and advances in biodegradation technologies.Archives of microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Antibiotic residues pose a serious threat to environmental safety. In this study, nitrogen/boron co-doped biochar (NBLB) was successfully prepared using lignosulfonate, an industrial byproduct, as the precursor via a one-step impregnation-pyrolysis method. NBLB was applied to activate peroxymonosulfate (PMS) to degrade tetracycline (TC) in water. The results showed that NBLB-activated PMS degraded 93.4% of TC within 60 min, which was 42.6%, 20.4%, and 27.8% higher than those of undoped biochar, nitrogen-doped biochar, and boron-doped biochar, respectively. Additionally, the NBLB/PMS system exhibited high tolerance to common aqueous anions such as Cl
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.